Ambee Pharmaceuticals PLC (DSE:AMBEEPHA)

Bangladesh flag Bangladesh · Delayed Price · Currency is BDT
837.70
-19.50 (-2.27%)
At close: Sep 1, 2025
-2.27%
Market Cap2.01B
Revenue (ttm)235.22M
Net Income (ttm)10.08M
Shares Out2.40M
EPS (ttm)4.20
PE Ratio199.36
Forward PEn/a
Dividend1.00 (0.12%)
Ex-Dividend Daten/a
Volume19,334
Average Volume8,917
Open860.00
Previous Close857.20
Day's Range836.20 - 867.80
52-Week Range675.00 - 1,002.70
Beta-0.36
RSI64.27
Earnings DateNov 3, 2025

About Ambee Pharmaceuticals

Ambee Pharmaceuticals PLC engages in the manufacture and sale of pharmaceuticals, chemicals, medicals, and other preparations in Bangladesh. The company offers products in various therapeutic areas, including analgesic and antipyretic, anti-helmintic, antacid, anti-histamine, anti-protozoal, anti-fungal, antiasthmatic and antitussive, antibacterial, anticonvulstant, antiemetic, antihypertensive, antilipidemic agents, antiosteoarthritic, antispasmodic, antituberculer, antiulcerant, anxiolytic and hypnotic, cerebral vasodilator, corticosteroid dr... [Read more]

Industry Pharmaceutical Preparations
Founded 1976
Employees 529
Stock Exchange Dhaka Stock Exchange
Ticker Symbol AMBEEPHA
Full Company Profile

Financial Performance

In 2024, Ambee Pharmaceuticals's revenue was 219.30 million, an increase of 10.71% compared to the previous year's 198.10 million. Earnings were 9.68 million, an increase of 6.53%.

Financial Statements

News

There is no news available yet.